Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Scilex Holding Co. (SCLX)

Scilex Holding Co. (SCLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Scilex Holding Co. 960 SAN ANTONIO ROAD PALO ALTO CA 94303 USA

www.scilexholding.com Employees: 105 P: 650-516-4310

Description:

Scilex Holding Company is a commercial biopharmaceutical company focused on developing and commercializing non-opioid therapies for patients with acute and chronic pain. Scilex Holding Company, formerly known as Vickers Vantage Corp. I, is based in PALO ALTO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 186,306
Enterprise Value, $K 307,856
Shares Outstanding, K 191,791
Annual Sales, $ 46,740 K
Annual Net Income, $ -114,330 K
Last Quarter Sales, $ 16,370 K
Last Quarter Net Income, $ -37,580 K
EBIT, $ -88,160 K
EBITDA, $ -83,950 K
60-Month Beta 1.14
% of Insider Shareholders 8.73%
% of Institutional Shareholders 69.67%
Float, K 175,048
% Float 91.27%
Short Volume Ratio 0.45

Growth:

1-Year Return -41.41%
3-Year Return -90.31%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.18 on 08/13/24
Next Earnings Date 11/12/24
Earnings Per Share ttm -1.32
EPS Growth vs. Prev Qtr 30.77%
EPS Growth vs. Prev Year -12.50%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SCLX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -111.82%
Profit Margin % -244.61%
Debt/Equity -0.49
Price/Sales 3.94
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.18
Interest Coverage -105.84
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar